Literature DB >> 19132829

Therapeutic index of gramicidin S is strongly modulated by D-phenylalanine analogues at the beta-turn.

Concepción Solanas1, Beatriz G de la Torre, María Fernández-Reyes, Clara M Santiveri, M Angeles Jiménez, Luis Rivas, Ana I Jiménez, David Andreu, Carlos Cativiela.   

Abstract

Analogues of the cationic antimicrobial peptide gramicidin S (GS), cyclo(Val-Orn-Leu-D-Phe-Pro)2, with d-Phe residues replaced by different (restricted mobility, mostly) surrogates have been synthesized and used in SAR studies against several pathogenic bacteria. While all D-Phe substitutions are shown by NMR to preserve the overall beta-sheet conformation, they entail subtle structural alterations that lead to significant modifications in biological activity. In particular, the analogue incorporating D-Tic (1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid) shows a modest but significant increase in therapeutic index, mostly due to a sharp decrease in hemolytic effect. The fact that NMR data show a shortened distance between the D-Tic aromatic ring and the Orn delta-amino group may help explain the improved antibiotic profile of this analogue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19132829      PMCID: PMC2659738          DOI: 10.1021/jm800886n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  49 in total

1.  Development of the structural basis for antimicrobial and hemolytic activities of peptides based on gramicidin S and design of novel analogs using NMR spectroscopy.

Authors:  C McInnes; L H Kondejewski; R S Hodges; B D Sykes
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

2.  Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity.

Authors:  L H Kondejewski; M Jelokhani-Niaraki; S W Farmer; B Lix; C M Kay; B D Sykes; R E Hancock; R S Hodges
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

3.  Optimization of microbial specificity in cyclic peptides by modulation of hydrophobicity within a defined structural framework.

Authors:  Leslie H Kondejewski; Darin L Lee; Masood Jelokhani-Niaraki; Susan W Farmer; Robert E W Hancock; Robert S Hodges
Journal:  J Biol Chem       Date:  2001-10-26       Impact factor: 5.157

4.  Synthesis and biological evaluation of novel turn-modified gramicidin S analogues.

Authors:  Gijsbert M Grotenbreg; Emile Spalburg; Albert J de Neeling; Gijsbert A van der Marel; Herman S Overkleeft; Jacques H van Boom; Mark Overhand
Journal:  Bioorg Med Chem       Date:  2003-07-03       Impact factor: 3.641

5.  Automated NMR structure calculation with CYANA.

Authors:  Peter Güntert
Journal:  Methods Mol Biol       Date:  2004

6.  Beta-turn modified gramicidin S analogues containing arylated sugar amino acids display antimicrobial and hemolytic activity comparable to the natural product.

Authors:  Gijsbert M Grotenbreg; Annelies E M Buizert; Antonio L Llamas-Saiz; Emile Spalburg; Peter A V van Hooft; Albert J de Neeling; Daan Noort; Mark J van Raaij; Gijsbert A van der Marel; Herman S Overkleeft; Mark Overhand
Journal:  J Am Chem Soc       Date:  2006-06-14       Impact factor: 15.419

Review 7.  Host defense peptides and the new line of defence against multiresistant infections.

Authors:  Tobias Hirsch; Frank Jacobsen; Hans-Ulrich Steinau; Lars Steinstraesser
Journal:  Protein Pept Lett       Date:  2008       Impact factor: 1.890

8.  Recommendations for the presentation of NMR structures of proteins and nucleic acids. IUPAC-IUBMB-IUPAB Inter-Union Task Group on the Standardization of Data Bases of Protein and Nucleic Acid Structures Determined by NMR Spectroscopy.

Authors:  J L Markley; A Bax; Y Arata; C W Hilbers; R Kaptein; B D Sykes; P E Wright; K Wüthrich
Journal:  J Biomol NMR       Date:  1998-07       Impact factor: 2.835

Review 9.  Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides.

Authors:  A Parisien; B Allain; J Zhang; R Mandeville; C Q Lan
Journal:  J Appl Microbiol       Date:  2008-01       Impact factor: 3.772

10.  Gramicidin S analogs with a D-Ala, Gly, or L-Ala residue in place of the D-Phe residue: molecular conformations and interactions with phospholipid membrane.

Authors:  T Higashijima; T Miyazawa; M Kawai; U Nagai
Journal:  Biopolymers       Date:  1986-12       Impact factor: 2.505

View more
  5 in total

1.  New approaches towards the synthesis of 1,2,3,4-tetrahydro isoquinoline-3-phosphonic acid (TicP).

Authors:  José Luis Viveros-Ceballos; Lizeth A Matías-Valdez; Francisco J Sayago; Carlos Cativiela; Mario Ordóñez
Journal:  Amino Acids       Date:  2021-03-01       Impact factor: 3.520

2.  On resin amino acid side chain attachment strategy for the head to tail synthesis of new glutamine containing gramicidin-S analogs and their antimicrobial activity.

Authors:  Safa Derbal; Mary Hensler; Weiqin Fang; Victor Nizet; Kamel Ghedira; Adel Nefzi
Journal:  Bioorg Med Chem Lett       Date:  2010-08-08       Impact factor: 2.823

3.  Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii.

Authors:  R López-Rojas; F Docobo-Pérez; M E Pachón-Ibáñez; B G de la Torre; M Fernández-Reyes; C March; J A Bengoechea; D Andreu; L Rivas; J Pachón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

4.  Sequence inversion and phenylalanine surrogates at the beta-turn enhance the antibiotic activity of gramicidin S.

Authors:  Concepción Solanas; Beatriz G de la Torre; María Fernández-Reyes; Clara M Santiveri; M Angeles Jiménez; Luis Rivas; Ana I Jiménez; David Andreu; Carlos Cativiela
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

5.  Structure, toxicity and antibiotic activity of gramicidin S and derivatives.

Authors:  J Swierstra; V Kapoerchan; A Knijnenburg; A van Belkum; M Overhand
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-17       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.